Carillon Tower: “HealthEquity (HQY) Benefits From a Rising Interest Rate Environment”

Carillon Tower Advisers, an investment management firm, published its “Carillon Scout Small Cap Fund” first quarter 2022 investor letter – a copy of which can be downloaded here. During the quarter, the management team added one new holding and eliminated two positions from the Fund portfolio. With very little cash, the portfolio remains fully invested. Try to spend some time taking a look at the fund’s top 5 holdings to be informed about their best picks for 2022.

In its Q1 2022 investor letter, Carillon Scout Small Cap Fund mentioned HealthEquity, Inc. (NASDAQ:HQY) and explained its insights for the company. Founded in 2002, HealthEquity, Inc. (NASDAQ:HQY) is a Draper, Utah-based financial technology and business services company with a $4.8 billion market capitalization. HealthEquity, Inc. (NASDAQ:HQY) delivered a 30.36% return since the beginning of the year, while its 12-month returns are down by -30.22%. The stock closed at $57.67 per share on July 04, 2022.

Here is what Carillon Scout Small Cap Fund has to say about HealthEquity, Inc. (NASDAQ:HQY) in its Q1 2022 investor letter:

HealthEquity (NASDAQ:HQY) works with consumers and employers to provide health savings accounts and other consumer-directed benefits. The company continues to gain market share and also benefits from a rising interest rate environment.”

Our calculations show that HealthEquity, Inc. (NASDAQ:HQY) fell short and didn’t make it on our list of the 30 Most Popular Stocks Among Hedge Funds. HealthEquity, Inc. (NASDAQ:HQY) was in 25 hedge fund portfolios at the end of the first quarter of 2022, compared to 26 funds in the previous quarter. HealthEquity, Inc. (NASDAQ:HQY) delivered a -14.37% return in the past 3 months.

In June 2022, we also shared another hedge fund’s views on HealthEquity, Inc. (NASDAQ:HQY) in another article. You can find other investor letters from hedge funds and prominent investors on our hedge fund investor letters 2022 Q1 page.

Disclosure: None. This article is originally published at Insider Monkey.